KCM
MRTX

Kynam Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Kynam Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-499,853
Closed -$18.6M – 35
2023
Q1 		$18.6M Buy
499,853
+308,695
+161% +$11.5M 2.4% 12
2022
Q4 		$8.66M Buy
+191,158
New +$8.66M 1.33% 18